NCT04622982

Brief Summary

This is an open label study in which obese participants were treated with a restrictive hypo-caloric diet under hospitalization for a maximum period of 3 months in a metabolic rehabilitation unit. A multidisciplinary approach was used (combination of diet, physical exercise and psychotherapy)

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
151

participants targeted

Target at P75+ for not_applicable obesity

Timeline
Completed

Started Feb 2016

Longer than P75 for not_applicable obesity

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2016

Completed
3.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 31, 2019

Completed
11 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2020

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

October 31, 2020

Completed
10 days until next milestone

First Posted

Study publicly available on registry

November 10, 2020

Completed
Last Updated

November 10, 2020

Status Verified

November 1, 2020

Enrollment Period

3.7 years

First QC Date

October 31, 2020

Last Update Submit

November 5, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • Body Weight

    Change in body Weight

    12 weeks

Secondary Outcomes (12)

  • GlycaemIa

    12 weeks

  • Insulin

    12 weeks

  • Homa IR

    12 weeks

  • Total cholesterol

    12 weeks

  • LDL cholesterol

    12 weeks

  • +7 more secondary outcomes

Other Outcomes (24)

  • Body composition - Body Fat Mass

    12 weeks

  • Body composition - Body Fat free mass

    12 weeks

  • Body composition - Visceral Fat mass

    12 weeks

  • +21 more other outcomes

Study Arms (1)

All participants

EXPERIMENTAL

Obese subjects with BMI \>= 30 and with one or more of metabolic comorbidities (type 2 diabetes mellitus, dyslipidemia, high blood pressure, hyperuricemia, and others).

Other: Multidisciplinary treatment of obesity (diet + vitamin D + exercise + psychotherapy)

Interventions

Body weight reduction was induced by a low-energy mixed diet (55 % carbohydrates, 30 % lipids and 15 % proteins) providing 600 kcal less than individually estimated energy requirements based on the measured REE. The energy content and macronutrient composition of the diets adhered to the nutritional recommendations of the American Diabetes Association. Patients were administered vitamin D supplement only if they presented a value of 25-hydroxyvitamin D (25OHD) \<30 ng/ml in blood tests at the beginning. Patients were following an individualized physical activity plan within the hospital and were aided by a psychodynamic approach therapist.

All participants

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • age \>= 18
  • BMI \>= 30
  • one or more comorbidities (type 2 diabetes mellitus, dyslipidemia, high blood pressure, hyperuricemia, and others)

You may not qualify if:

  • active cancer
  • severe cognitive or functional impairments
  • severe behavioral disorders
  • known kidney failure (previous glomerular filtration rate \<30 ml/min)
  • known liver failure (Child B or C)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Obesity

Interventions

DietVitamin DExercisePsychotherapy

Condition Hierarchy (Ancestors)

OverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Nutritional Physiological PhenomenaDiet, Food, and NutritionPhysiological PhenomenaSecosteroidsSteroidsFused-Ring CompoundsPolycyclic CompoundsMotor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological PhenomenaBehavioral Disciplines and Activities

Study Officials

  • Mariangela Rondanelli, MD, PhD

    Azienda di Servizi alla Persona di Pavia

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: Open Label study
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 31, 2020

First Posted

November 10, 2020

Study Start

February 1, 2016

Primary Completion

October 31, 2019

Study Completion

September 30, 2020

Last Updated

November 10, 2020

Record last verified: 2020-11

Data Sharing

IPD Sharing
Will not share

IPD are not shared. Published article will display mean baseline values and mean differences from baseline.